Tumor invasion in the absence of epithelial-mesenchymal transition: Podoplanin-mediated remodeling of the actin cytoskeleton

Andreas Wicki, François Lehembre, Nikolaus Wick, +3

Cancer Cell

Tumor InvasionDevelopmental BiologyActin CytoskeletonPodoplanin-mediated RemodelingCell-matrix Interaction +10

The SUMO Pathway Is Essential for Nuclear Integrity and Chromosome Segregation in Mice

Karim Nacerddine, François Lehembre, Mantu Bhaumik, +5

Developmental Cell

ChromatinGenome InstabilityChromosome SegregationGeneticsMeiosis +7

c-Jun and p53 Activity Is Modulated by SUMO-1 Modification

Stefan Müller, Michael Berger, François Lehembre, +3

Journal of Biological Chemistry

Hepatocyte growth factor induces cell scattering through MAPK/Egr‐1‐mediated upregulation of Snail

Stefan Grotegut, Dietrich von Schweinitz, Gerhard Christofori, +1

The EMBO Journal

NCAM‐induced focal adhesion assembly: a functional switch upon loss of E‐cadherin

François Lehembre, M. Deniz Yilmaz, Andreas Wicki, +9

The EMBO Journal

Regulation of Pax3 transcriptional activity by SUMO-1-modified PML

François Lehembre, Stefan Müller, Pier Paolo Pandolfi, +1

Oncogene

Transcriptional RegulationMolecular RegulationNatural SciencesGene RegulationSumo-1-modified Pml +6

Increased tumor cell dissemination and cellular senescence in the absence of β1‐integrin function

Angelika Kren, Vanessa Baeriswyl, François Lehembre, +6

The EMBO Journal

Covalent Modification of the Transcriptional Repressor Tramtrack by the Ubiquitin-Related Protein Smt3 in <i>Drosophila</i> Flies

François Lehembre, Paul Badenhorst, Stefan Müller, +3

Molecular and Cellular Biology

ChromatinTranscriptional RegulationUbiquitin-related Protein Smt3Natural SciencesGenetics +13

Transcription factor Dlx2 protects from TGFβ‐induced cell‐cycle arrest and apoptosis

M. Deniz Yilmaz, Dorothea Maaß, Neha Tiwari, +4

The EMBO Journal

Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

Sun-Jin Kim, Ho Jeong Lee, Mark Seungwook Kim, +11

Clinical Cancer Research